A 4-month regimen recommended for drug-susceptible TB and 6-month regimen recommended for drug-resistant TB.

Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people ...

"While these new regimens have allowed significant treatment shortening, it is important to recognize that drug-resistance in TB isolates could emerge with incomplete adherence to these regimens ...

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children.

Background: Patients on anti-tuberculosis treatment may develop acute kidney injury (AKI), but little is known about the renal outcome and prognostic factors, especially in an aging population.

Hence, there is a great potential of mannose-targeted drug delivery systems for the treatment of macrophage-related diseases. Therefore, the treatment of pulmonary TB can also benefit from the use ...

Survivors of TB may benefit from improved linkage to care, with post-treatment mortality associated with HIV, alcohol use, diabetes, and end-stage kidney disease.

Tuberculosis remains a public health crisis. The World Health Organization's Global Tuberculosis Report released in November 2024 painted a sobering picture; approximately 8.2 million people were ...

Multidrug resistant tuberculosis (MDR-TB) is a serious, life-threatening illness with evolving treatment regimens for better ...

DelveInsight's 'Tuberculosis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline tuberculosis ...

Rising multi-drug resistant TB cases in Kozhikode prompt urgent action in ongoing eradication campaign by Health department.